NSCLC: bridging the gap between clinical progress and real-world application.
出版信息
Lancet Reg Health Eur. 2024 Mar 4;38:100878. doi: 10.1016/j.lanepe.2024.100878. eCollection 2024 Mar.
Abstract
摘要
相似文献
1
NSCLC: bridging the gap between clinical progress and real-world application.
Lancet Reg Health Eur. 2024 Mar 4;38:100878. doi: 10.1016/j.lanepe.2024.100878. eCollection 2024 Mar.
2
[Progress in methodological research on bridging the efficacy-effectiveness gap of clinical interventions (1): to improve the validity of real-world evidence].
Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Feb 10;45(2):286-293. doi: 10.3760/cma.j.cn112338-20230925-00189.
3
Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC.
BMC Med Res Methodol. 2023 Jan 3;23(1):1. doi: 10.1186/s12874-022-01760-0.
4
Real-world adherence and persistence with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer.
J Manag Care Spec Pharm. 2022 Mar;28(3):305-314. doi: 10.18553/jmcp.2021.21310. Epub 2021 Dec 16.
5
Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands.
Sci Rep. 2021 Mar 18;11(1):6306. doi: 10.1038/s41598-021-85696-3.
6
Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).
Lung Cancer. 2020 Aug;146:112-119. doi: 10.1016/j.lungcan.2020.05.033. Epub 2020 May 31.
7
Real-World Treatment Patterns and Outcomes of First-Line Immunotherapy Among Patients With Advanced Nonsquamous NSCLC Harboring , , or Alterations.
JTO Clin Res Rep. 2023 Aug 23;4(10):100568. doi: 10.1016/j.jtocrr.2023.100568. eCollection 2023 Oct.
8
Effectiveness of crizotinib in patients with -positive non-small-cell lung cancer: real-world evidence in Japan.
Future Oncol. 2023 Dec;19(37):2453-2463. doi: 10.2217/fon-2023-0109. Epub 2023 Aug 22.
9
Efficacy and Effectiveness: Bridging the Gap Between Clinical Trials and Real-world Practice.
Eur Urol Oncol. 2024 Feb;7(1):25-26. doi: 10.1016/j.euo.2023.06.010. Epub 2023 Jul 20.
10
Real-world studies: bridging the gap between trial-assessed efficacy and routine care.
J Biomed Res. 2022 May 10;36(3):147-154. doi: 10.7555/JBR.36.20220040.
引用本文的文献
1
Real-World Treatment Patterns and Outcomes Among Patients with Early Non-Small Cell Lung Cancer.
Curr Oncol. 2025 Apr 19;32(4):239. doi: 10.3390/curroncol32040239.
Zotero 插件